Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 01/13/2015 12:37:34 PM
Post# of 30066
Posted By: Mutai803
Fumi Blog:

13 Jan 2015
Progenitor Cells Secreting GDNF for the Treatment of ALS

I learned about another interesting clinical trial at the regenerative therapy group meeting last week.
http://www.cirm.ca.gov/our-progress/awards/pr...atment-als

In this clinical trial, scientists transplant neural progenitor cells expressing GNDF to patients with ALS, an incurable neurodegenerative disorder. What is GDNF? GDNF is a neurotrophic factor like MANF and promotes the growth of neural cells. They expect that neural progenitor cells expressing GDNF protects neuronal cell death in patients with ALS. Can we use the same strategy for MANF? We can potentially create neural progenitor cells from Wolfram syndrome patients expressing MANF and transplant them to our patients.

Thank you for taking your time to read this one. I hope you have a wonderful day.

Take care,













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site